Lactosylated liposomes for targeted delivery of doxorubicin to hepatocellular carcinoma

References

• El-SeragHBRudolphLHepatocellular carcinoma: epidemiology and molecular carcinogenesisGastroenterology20071322557257617570226
   PubMed Web of Science ®Google Scholar
• GabizonADaganAGorenDBarenholzYFuksZLiposomes as in vivo carriers of adriamycin: reduced cardiac uptake and preserved antitumor activity in miceCancer Res198242473447397127308
   PubMed Web of Science ®Google Scholar
• SafraTMuggiaFJeffersSPegylated liposomal doxorubicin (doxil): reduced clinical cardiotoxicity in patients reaching or exceeding cumulative doses of 500 mg/m2Ann Oncol2000111029103311038041
   PubMed Web of Science ®Google Scholar
• YanXScherphofGLKampsJALiposome opsonizationJ Liposome Res20051510913916194930
   PubMed Web of Science ®Google Scholar
• HashidaMNishikawaMTakakuraYHepatic targeting of drugs and proteins by chemical modificationJ Control Release19953699107
   Web of Science ®Google Scholar
• RensenPCSliedregtLAFernsMDetermination of the upper size limit for uptake and processing of ligands by the asialoglycoprotein receptor on hepatocytes in vitro and in vivoJ Biol Chem2001276375773758411479285
   PubMed Web of Science ®Google Scholar
• SeymourLWFerryDRAndersonDHepatic drug targeting: phase 1 evaluation of polymer-bound doxorubicinJ Clin Oncol2002201668167611896118
   PubMed Web of Science ®Google Scholar
• WuJNantzMHZernMATargeting hepatocytes for drug and gene delivery: emerging novel approaches and applicationsFront Biosci20027717725
   PubMed Web of Science ®Google Scholar
• SuoAQianJYaoYZhangWGalactosylated poly(ethylene glycol)-b-poly (L-lactide-co-β-malic acid) block copolymer micelles for targeted drug delivery: preparation and in vitro characterizationInt J Nanomedicine201051029103821170351
   PubMed Web of Science ®Google Scholar
• ManagitCKawakamiSYamashitaFHashidaMEffect of galaclactose density on asialoglycoprotein receptor-mediated uptake of galactosylated liposomesJ Pharm Sci2005942266227516136555
   PubMed Web of Science ®Google Scholar
• HattoriYKawakamiSYamashitaFHashidaMControlled biodistribution of galactosylated liposomes and incorporated probucol in hepatocyte-selective drug targetingJ Control Release20006936937711102677
   PubMed Web of Science ®Google Scholar
• ManagitCKawakamiSYamashitaFHashidaMUptake characteristics of galactosylated emulsion by HepG2 hepatoma cellsInt J Pharm200530125526116076536
   PubMed Web of Science ®Google Scholar
• WangSXuHXuJSynthesis of a novel galactosylated lipid and its application to the hepatocyte-selective targeting of liposomal doxorubicinEur J Pharm Biopharm200662323816226883
   PubMed Web of Science ®Google Scholar
• TeradaTIwaiMKawakamiSYamashitaFHashidaMNovel PEG-matrix metalloproteinase-2 cleavable peptide-lipid containing galactosylated liposomes for hepatocellular carcinoma-selective targetingJ Control Release200611133334216488046
   PubMed Web of Science ®Google Scholar
• XuZChenLGuWThe performance of docetaxel-loaded solid lipid nanoparticles targeted to hepatocellular carcinomaBiomaterials20093022623218851881
   PubMed Web of Science ®Google Scholar
• SzokaFOlsonFHeathTVailWMayhewEPapahadjopoulosDReparation of unilamellar liposomes of intermediate size (0.1–0.2 μM) by a combination of reverse phase evaporation and extrusion through polycarbonate membranesBiochim Biophys Acta19806015595716251878
   PubMed Web of Science ®Google Scholar
• PanXQWangHLeeRJAntitumor activity of folate receptor-targeted liposomal doxorubicin in a KB oral carcinoma murine xenograft modelPharm Res20032041742212669962
   PubMed Web of Science ®Google Scholar
• LeeRJLowPSFolate-mediated tumor cell targeting of liposome-entrapped doxorubicin in vitroBiochim Biophys Acta199512331341447865538
   PubMed Web of Science ®Google Scholar
• LiHLuYPiaoLTargeting human clonogenic acute myelogenous leukemia cells via folate conjugated liposomes combined with receptor modulation by all-trans retinoic acidInt J Pharm2010402576320883757
   PubMed Web of Science ®Google Scholar
• MarksDCBelovLDaveyMWDaveyRAKidmanADThe MTT cell viability assay for cytotoxicity testing in multidrug-resistant human leukemic cellsLeuk Res199216116511731361210
   PubMed Web of Science ®Google Scholar
• XuSLiuYTaiHCZhuJDingHLeeRJSynthesis of transferrin (Tf) conjugated liposomes via Staudinger ligationInt J Pharm201140420521021056642
   PubMed Web of Science ®Google Scholar
• HongRLHuangCJTsengYLDirect comparison of liposomal doxorubicin with or without polyethylene glycol coating in C-26 tumor-bearing mice: is surface coating with polyethylene glycol beneficial?Clin Cancer Res199953645365210589782
   PubMed Web of Science ®Google Scholar
• TagamiTErnstingMJLiSDEfficient tumor regression by a single and low dose treatment with a novel and enhanced formulation of thermosensitive liposomal doxorubicinJ Control Release201115230330921338635
   PubMed Web of Science ®Google Scholar
• LaginhaKMVerwoertSCharroisGJAllenTMDetermination of doxorubicin levels in whole tumor and tumor nuclei in murine breast cancer tumorsClinCancer Res20051169446949
   Google Scholar
• HanHDLeeAHwangTEnhanced circulation time and antitumor activity of doxorubicin by comblike polymer-incorporated liposomesJ Control Release200712016116817524514
   PubMed Web of Science ®Google Scholar
• WangSDengYXuHWuHQiuYChenDSynthesis of a novel galactosylated lipid and its application to the hepatocyte-selective targeting of liposomal doxorubicinEur J Pharm Biopharm200662323816226883
   PubMed Web of Science ®Google Scholar
• AllenTMLong-circulating (sterically stabilized) liposomes for targeted drug deliveryTrends Pharmacol Sci1994152152207940982
   PubMed Web of Science ®Google Scholar
• GabizonAPapahadjopoulosDLiposome formulations with prolonged circulation time in blood and enhanced uptake by tumorsProc Natl Acad Sci U S A198885694969533413128
   PubMed Web of Science ®Google Scholar
• WoodleMCLasicDDSterically stabilized liposomesBiochim Biophys Acta199211131711991510996
   PubMed Web of Science ®Google Scholar
• MayerLDTaiLCKoDSInfluence of vesicle size, lipid composition, and drug-to-lipid ratio on the biological activity of liposomal doxorubicin in miceCancer Res198949592259302790807
   PubMed Web of Science ®Google Scholar
• GabizonAASelective tumor localization and improved therapeutic index of anthracyclines encapsulated in long-circulating liposomesCancer Res1992528918961737351
   PubMed Web of Science ®Google Scholar
• JainNKJainSKDevelopment and in vitro characterization of galactosylated low molecular weight chitosan nanoparticles bearing doxorubicinAAPS PharmSciTech20101168669720414758
   PubMed Web of Science ®Google Scholar
• BernardesGJKikkeriRMaglinaoMDesign, synthesis and biological evaluation of carbohydrate-functionalized cyclodextrins and the liposomes for hepatocyte-specific targetingOrg Biomol Chem201084987499620820666
   PubMed Web of Science ®Google Scholar
• KikkeriRLepeniesBAdibekianALauorinoPSeebergerPHIn vitro imaging and in vivo liver targeting with carbohydrate capped quantum dotsJ Am Chem Soc20091312110211219199612
   PubMed Web of Science ®Google Scholar
• HiguchiYOkaMKawakamiSHashidaMMannosylated semiconductor quantum dots for the labeling of macrophagesJ Control Release200812513113618045722
   PubMed Web of Science ®Google Scholar
• LongmuirKJHaynesSMBarattaJLKasabwallaNRobertsonRTLiposomal delivery of doxorubicin to hepatocytes in vivo by targeting heparin sulfateInt J Pharm200938222223319664697
   PubMed Web of Science ®Google Scholar
• GewirtzDAA critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicinBiochem Pharmacol19995772774110075079
   PubMed Web of Science ®Google Scholar